News

An early-phase study potentially links hallucinogenic psilocybin to the relief of cancer-related depression and anxiety.

A recent study indicates that having a strong social network could improve survival of patients with breast cancer.

President Barack Obama signs the 21st Century Cures Act into law.

Women experiencing symptoms of menopause are less likely to adhere to treatment.

According to a recent study, postmenopausal women with early-stage breast cancer may be at risk of cardiovascular disease from aromatase inhibitor therapy.

The National Leiomyosarcoma Foundation offers tips for caregivers in this holiday season.

Modern scalp-cooling system is safe and effective in reducing hair loss in women being treated with chemotherapy for their breast cancer, especially for those on taxane-based regimens.

According to findings from a phase II trial, prophylactic treatment with a combination of loperamide and budesonide reduced the rate of all-grade diarrhea associated with neratinib to 65%, compared with 95.4% observed in the ExteNET trial.

A second round of chemotherapy or stem cell transplant for patients with multiple myeloma does not improve PFS or OS compared to the current standard couse of treatment.

According to phase II trial findings, adding everolimus to fulvestrant significantly improved progression-free survival for postmenopausal patients with metastatic hormone receptor-positive, HER2-negative breast cancer who are resistant to aromatase inhibitor therapy.

SHARE's video series featuring women with metastatic breast cancer.

SHARE online support communities for patients with ovarian cancer, breast cancer, and metastatic breast cancer.

Pembrolizumab linked to improved quality of life for patients with non-small cell lung cancer (NSCLC), according to data from KEYNOTE-024 trial.

Be the Match shares ways to help raise funds for their Foundation.

The FDA has expanded the approval of bevacizumab to include platinum-sensitive recurrent ovarian cancer.

Upcoming studies at OSUCCC – James aim to determine the health effects of "vaping," smoking electronic cigarettes (e-cigarettes, or e-cigs) as compared to traditional cigarettes and on their own.

Five-year follow-up on ibrutinib (Imbruvica) shows efficacy and safety for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with 89% of both treatment-naïve (TN) and relapsed patients experiencing a complete or partial response to the therapy.

ASCO has released its Criteria for High-Quality Clinical Pathways in Oncology, assessing the quality, utility, and integrity of clinical pathways in oncology.

Combination pembrolizumab (Keytruda), pomalidomide (Pomalyst), and dexamethasone shows benefit for patients with relapsed/refractory multiple myeloma.

Mikel Ross discusses scalp cooling and how this treatment is changing the landscape for chemotherapy-induced alopecia.

The US House of Representatives has passed the 21st Century Cure Act which allots funding to NIH, FDA, the Cancer Moonshot and other health initiatives.

Karen Lee discusses the managment of immune-related adverse events in patients who are receiving immunotherapy treatments.

Bonnie J. Addario Lung Cancer Foundation and American Lung Associate have teamed up to create a lung Cancer Registry to connect patients with lung cancer with opportunities to support research and engage with others in the community.

Patients with cancer can be vulnerable to to caregiver abuse and should know the warning signs.

Nonburning sun exposure is associated with a reduced risk of melanoma, while sunburns are associated with a doubling of the risk of melanoma

Somatostatin analog lanreotide (Somatuline Depot) is being considered for patients with lung neuroendocrine tumors (NETs) in a potentially practice-changing clinical trial.

While palliative care interventions improve patients' quality of life, there is no survival benefit.

Kathy LaTour shares her holiday experience with cancer and the tips she's learned since.

Recent research highlights the unmet psychological needs for older breast cancer survivors.